Virginia Drug Discovery Consortium

The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:

To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.

To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.

To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.

Work with us

EVENTS

The VaDDC Executive Committee regrets to announce:

VirginiaDrugDiscoveryRx: Targets to Translation

Double Tree Hotel, Midlothian, VA – May 18 – 19, 2020

HAS BEEN CANCELLED UNTIL NEXT YEAR DUE TO THE COVID-19 PANDEMIC

NEWS

Virginia Company, Phlow Corp. Awarded $354 million to Produce Ingredients for Covid-19 Drugs

A new Richmond-based pharmaceutical manufacturing company has received a $354 million federal contract to make the active ingredients for more than a dozen medicines used to treat patients with COVID-19. And the ingredients will be made at a pharmaceutical plant in...

Virginia Bio Names John Newby CEO

Virginia Bio announces John Newby will become CEO of Virginia Bio starting August 5, 2019. John will be stepping down as Commissioner of the Virginia Department of Veterans Services, where for the last 7 years he led this 800-member Agency located across more than 40...

Webster Santos – VT and Kevin Lynch-UVA received a $2.8 NIAID grant to Develop a Drug to Treat Multiple Sclerosis

Santos received this research grant in collaboration with Kevin Lynch, a professor of pharmacology at the University of Virginia. Lynch will oversee the biological testing of the drug. The NIAID award builds on an existing research grant from the National Institute of...